Inotiv
NOTV
#10058
Rank
HK$0.22 B
Marketcap
HK$6.46
Share price
2.76%
Change (1 day)
-78.83%
Change (1 year)

P/E ratio for Inotiv (NOTV)

P/E ratio as of December 2025 (TTM): -0.3051

According to Inotiv's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.305148. At the end of 2024 the company had a P/E ratio of -0.8980.

P/E ratio history for Inotiv from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-0.8980-68.19%
2023-2.82662.35%
2022-0.3703-96.88%
2021-11.9-69.17%
2020-38.455.3%
2019-24.7-41.54%
2018-42.3-295.52%
201721.7-1022.04%
2016-2.35-107.72%
201530.4
2013-1365678.68%
2012-2.34

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
NRC Health
NRC
22.9-7,599.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-3.33 992.37% Bahamas

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.